Total Payments
$1,252
2024 Payments
$353.14
Companies
11
Transactions
60
Medicare Patients
2,250
Medicare Billing
$261,276
Payment Breakdown by Category
Food & Beverage$1,252 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,252 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $646.44 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $138.02 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $132.65 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $100.38 | 5 | $0 (2022) |
| Novo Nordisk Inc | $80.95 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $36.30 | 2 | $0 (2022) |
| PFIZER INC. | $35.41 | 2 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $33.66 | 2 | $0 (2023) |
| W. L. Gore & Associates, Inc. | $19.08 | 1 | $0 (2022) |
| Lexicon Pharmaceuticals, Inc. | $15.38 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $353.14 | 15 | AstraZeneca Pharmaceuticals LP ($225.51) |
| 2023 | $365.43 | 17 | AstraZeneca Pharmaceuticals LP ($260.90) |
| 2022 | $482.42 | 25 | AstraZeneca Pharmaceuticals LP ($160.03) |
| 2021 | $51.20 | 3 | E.R. Squibb & Sons, L.L.C. ($18.11) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 07/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Cardiovascular | ||||||
| 03/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 12/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Cardiovascular | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/25/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Cardiovascular | ||||||
| 07/13/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/07/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 871 | 1,143 | $250,171 | $102,653 |
| 2022 | 12 | 1,024 | 1,363 | $276,876 | $117,221 |
| 2021 | 11 | 355 | 500 | $100,504 | $41,402 |
Total Patients
2,250
Total Services
3,006
Medicare Billing
$261,276
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 165 | 336 | $53,416 | $22,477 | 42.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 213 | 216 | $56,818 | $22,426 | 39.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 147 | 207 | $49,462 | $21,541 | 43.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 124 | 127 | $44,544 | $17,653 | 39.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 136 | 137 | $31,646 | $12,608 | 39.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 52 | 86 | $8,570 | $3,742 | 43.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 34 | 34 | $5,714 | $2,206 | 38.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 254 | 408 | $85,295 | $37,908 | 44.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 202 | 350 | $50,911 | $22,560 | 44.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 150 | 152 | $32,674 | $14,239 | 43.6% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 115 | 118 | $31,922 | $12,019 | 37.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 82 | 82 | $22,652 | $8,702 | 38.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 50 | 51 | $20,642 | $8,298 | 40.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $9,131 | $3,568 | 39.1% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 35 | 37 | $7,632 | $3,142 | 41.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 46 | 75 | $5,932 | $2,633 | 44.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 39 | 39 | $5,713 | $2,414 | 42.3% |
| 99218 | Initial hospital observation care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,201 | $906.15 | 41.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 15 | 15 | $2,173 | $833.17 | 38.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 88 | 162 | $34,166 | $14,351 | 42.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 83 | 147 | $21,577 | $9,162 | 42.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 49 | 49 | $10,661 | $4,569 | 42.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 21 | $8,590 | $3,436 | 40.0% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 26 | 26 | $7,133 | $2,881 | 40.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $4,726 | $1,819 | 38.5% |
About Dr. Duo Jin, MD
Dr. Duo Jin, MD is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2018. The National Provider Identifier (NPI) number assigned to this provider is 1699254706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duo Jin, MD has received a total of $1,252 in payments from pharmaceutical and medical device companies, with $353.14 received in 2024. These payments were reported across 60 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,252).
As a Medicare-enrolled provider, Jin has provided services to 2,250 Medicare beneficiaries, totaling 3,006 services with total Medicare billing of $261,276. Data is available for 3 years (2021–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Valhalla, NY
- Active Since 08/09/2018
- Last Updated 05/06/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699254706
Products in Payments
- FARXIGA (Drug) $358.77
- LOKELMA (Drug) $287.67
- XARELTO (Drug) $132.65
- ENTRESTO (Drug) $100.38
- ELIQUIS (Drug) $90.91
- Ozempic (Drug) $66.55
- CAMZYOS (Drug) $62.18
- PAXLOVID (Drug) $20.34
- GORE CARDIOFORM Septal Occluder (Device) $19.08
- REBYOTA (Biological) $16.70
- Inpefa (Drug) $15.38
- Rybelsus (Drug) $14.40
- GIVLAARI (Drug) $13.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Internal Medicine $96,684
Luciano De Marco, M.d, M.D
Internal Medicine — Payments: $14,149
Internal Medicine $14,149
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Internal Medicine $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Internal Medicine $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Internal Medicine $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880
Internal Medicine $2,880